Dundee spin-out Ex Scientia signs collaboration agreement with US-based pharmaceutical Sunovion.
Ex Scientia, a drug discovery spin-out of Dundee University, has signed a collaboration agreement worth $4.8m with US-based Sunovion Pharmaceuticals. The deal will see the two companies research new therapies for psychiatric disorders.
Ex Scientia has received an upfront payment of $1m. The agreement gives Sunovion exclusive worldwide rights to drugs discovered. The spin-out meanwhile retains all rights to its technology.
Ex Scientia’s technology, a systematic algorithmic discovery platform, is able to program specific targets into a compound. Crucially, and…
